Peter Pitts

All articles by Peter Pitts

In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissi

Opinion: Understanding the FDA’s Take on Cannabidiol

Peter Pitts

February 19, 2019

In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol.

Next post in General Oncology

Peter Pitts

All articles by Peter Pitts

Opinion: Understanding the FDA’s Take on Cannabidiol

Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing